{"id":688249,"date":"2022-09-22T16:18:48","date_gmt":"2022-09-22T20:18:48","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-to-announce-half-year-2022-financial-results-on-september-28-2022\/"},"modified":"2022-09-22T16:18:48","modified_gmt":"2022-09-22T20:18:48","slug":"nanobiotix-to-announce-half-year-2022-financial-results-on-september-28-2022","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-to-announce-half-year-2022-financial-results-on-september-28-2022\/","title":{"rendered":"Nanobiotix to Announce Half Year 2022 Financial Results on September 28, 2022"},"content":{"rendered":"

<\/p>\n

Nanobiotix to Announce Half Year 2022 Financial Results on September 28, 2022<\/b><\/p>\n

Conference Call and Webcast to be Held at 8:00 AM ET \/ 2:00 PM CET on September 29, 2022<\/i><\/b><\/p>\n

PARIS & CAMBRIDGE, Mass.–(BUSINESS WIRE<\/a>)–
\nRegulatory News:\n<\/p>\n

NANOBIOTIX<\/a> (Euronext: NANO \u2013\u2013 NASDAQ: NBTX \u2013 the \u2018\u2018Company<\/b>\u2019\u2019), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced that it will report its financial results for half-year ending June 30, 2022, on Wednesday, September 28, 2022, after the close of the US market.\n<\/p>\n

\nThe announcement will be followed by a conference call and live audio webcast on Thursday, September 29, 2022, at 8:00 AM ET \/ 2:00 PM CET. During the call, Laurent Levy, chief executive officer, and Bart Van Rhijn, chief financial officer, will briefly review the Company\u2019s half-year results and provide an update on business activities before taking questions from participants.\n<\/p>\n

\nA live webcast of the call may be accessed by visiting the investors section of the company’s website at www.nanobiotix.com<\/a>. Participants may register for the call here<\/a>. They will be able to join the call via dial-in or one-click dial-out. It is recommended to join 10 minutes prior the event start.
\n
Participants are invited to email their questions in advance to investors@nanobiotix.com<\/a>.\n<\/p>\n

\nA replay of the webcast will be available shortly after the conclusion of the call and will be archived on the company’s website.\n<\/p>\n

\n***\n<\/p>\n

About NANOBIOTIX<\/b><\/p>\n

\nNanobiotix is a late-stage clinical biotechnology company pioneering disruptive, physics-based therapeutic approaches to revolutionize treatment outcomes for millions of patients; supported by people committed to making a difference for humanity. The company is leveraging its proprietary nanoparticle platform, including its lead product candidate, radiotherapy-activated NBTXR3, to develop a pipeline of therapeutic options designed to enhance local and systemic control of solid tumors with an initial focus on the treatment of head and neck cancers.\n<\/p>\n

\nFor more information about Nanobiotix, visit us at www.nanobiotix.com<\/a> or follow us on LinkedIn<\/a> and Twitter<\/a>.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20220922005704\/en\/<\/a><\/span><\/p>\n

Nanobiotix<\/i><\/p>\n

Communications Department
\n<\/b>
Brandon Owens
\n<\/i>
VP, Communications
\n<\/i>
+1 (617) 852-4835
\n
contact@nanobiotix.com<\/a><\/p>\n

Investor Relations Department
\n<\/b>
Kate McNeil
\n<\/i>
SVP, Investor Relations
\n<\/i>
+1 (609) 678-7388
\n
investors@nanobiotix.com<\/a><\/p>\n

Media Relations<\/i><\/p>\n

\nFR \u2013 Ulysse Communication
\n<\/b>
Pierre-Louis Germain
\n
+ 33 (0) 6 64 79 97 51
\n
plgermain@ulysse-communication.com<\/a><\/p>\n

\nGlobal \u2013 LifeSci Advisors
\n<\/b>
Ligia Vela-Reid
\n
+44 (0) 7413825310
\n
Lvela-reid@lifesciadvisors.com<\/a><\/p>\n

KEYWORDS:<\/b> Europe United States North America France Massachusetts<\/p>\n

INDUSTRY KEYWORDS:<\/b> Biotechnology Other Health Health Clinical Trials Oncology<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Nanobiotix to Announce Half Year 2022 Financial Results on September 28, 2022 Conference Call and Webcast to be Held at 8:00 AM ET \/ 2:00 PM CET on September 29, 2022 PARIS & CAMBRIDGE, Mass.–(BUSINESS WIRE)– Regulatory News: NANOBIOTIX (Euronext: NANO \u2013\u2013 NASDAQ: NBTX \u2013 the \u2018\u2018Company\u2019\u2019), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced that it will report its financial results for half-year ending June 30, 2022, on Wednesday, September 28, 2022, after the close of the US market. The announcement will be followed by a conference call and live audio webcast on Thursday, September 29, 2022, at 8:00 AM ET \/ 2:00 PM CET. During the call, Laurent … <\/p>\n

Continue reading “Nanobiotix to Announce Half Year 2022 Financial Results on September 28, 2022”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-688249","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nNanobiotix to Announce Half Year 2022 Financial Results on September 28, 2022 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-to-announce-half-year-2022-financial-results-on-september-28-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanobiotix to Announce Half Year 2022 Financial Results on September 28, 2022 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Nanobiotix to Announce Half Year 2022 Financial Results on September 28, 2022 Conference Call and Webcast to be Held at 8:00 AM ET \/ 2:00 PM CET on September 29, 2022 PARIS & CAMBRIDGE, Mass.–(BUSINESS WIRE)– Regulatory News: NANOBIOTIX (Euronext: NANO \u2013\u2013 NASDAQ: NBTX \u2013 the \u2018\u2018Company\u2019\u2019), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced that it will report its financial results for half-year ending June 30, 2022, on Wednesday, September 28, 2022, after the close of the US market. The announcement will be followed by a conference call and live audio webcast on Thursday, September 29, 2022, at 8:00 AM ET \/ 2:00 PM CET. During the call, Laurent … Continue reading "Nanobiotix to Announce Half Year 2022 Financial Results on September 28, 2022"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-to-announce-half-year-2022-financial-results-on-september-28-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-22T20:18:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20220922005704r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanobiotix-to-announce-half-year-2022-financial-results-on-september-28-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanobiotix-to-announce-half-year-2022-financial-results-on-september-28-2022\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Nanobiotix to Announce Half Year 2022 Financial Results on September 28, 2022\",\"datePublished\":\"2022-09-22T20:18:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanobiotix-to-announce-half-year-2022-financial-results-on-september-28-2022\\\/\"},\"wordCount\":399,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanobiotix-to-announce-half-year-2022-financial-results-on-september-28-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20220922005704r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanobiotix-to-announce-half-year-2022-financial-results-on-september-28-2022\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanobiotix-to-announce-half-year-2022-financial-results-on-september-28-2022\\\/\",\"name\":\"Nanobiotix to Announce Half Year 2022 Financial Results on September 28, 2022 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanobiotix-to-announce-half-year-2022-financial-results-on-september-28-2022\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanobiotix-to-announce-half-year-2022-financial-results-on-september-28-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20220922005704r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2022-09-22T20:18:48+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanobiotix-to-announce-half-year-2022-financial-results-on-september-28-2022\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanobiotix-to-announce-half-year-2022-financial-results-on-september-28-2022\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanobiotix-to-announce-half-year-2022-financial-results-on-september-28-2022\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20220922005704r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20220922005704r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nanobiotix-to-announce-half-year-2022-financial-results-on-september-28-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nanobiotix to Announce Half Year 2022 Financial Results on September 28, 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nanobiotix to Announce Half Year 2022 Financial Results on September 28, 2022 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-to-announce-half-year-2022-financial-results-on-september-28-2022\/","og_locale":"en_US","og_type":"article","og_title":"Nanobiotix to Announce Half Year 2022 Financial Results on September 28, 2022 - Market Newsdesk","og_description":"Nanobiotix to Announce Half Year 2022 Financial Results on September 28, 2022 Conference Call and Webcast to be Held at 8:00 AM ET \/ 2:00 PM CET on September 29, 2022 PARIS & CAMBRIDGE, Mass.–(BUSINESS WIRE)– Regulatory News: NANOBIOTIX (Euronext: NANO \u2013\u2013 NASDAQ: NBTX \u2013 the \u2018\u2018Company\u2019\u2019), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced that it will report its financial results for half-year ending June 30, 2022, on Wednesday, September 28, 2022, after the close of the US market. The announcement will be followed by a conference call and live audio webcast on Thursday, September 29, 2022, at 8:00 AM ET \/ 2:00 PM CET. During the call, Laurent … Continue reading \"Nanobiotix to Announce Half Year 2022 Financial Results on September 28, 2022\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-to-announce-half-year-2022-financial-results-on-september-28-2022\/","og_site_name":"Market Newsdesk","article_published_time":"2022-09-22T20:18:48+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20220922005704r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-to-announce-half-year-2022-financial-results-on-september-28-2022\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-to-announce-half-year-2022-financial-results-on-september-28-2022\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Nanobiotix to Announce Half Year 2022 Financial Results on September 28, 2022","datePublished":"2022-09-22T20:18:48+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-to-announce-half-year-2022-financial-results-on-september-28-2022\/"},"wordCount":399,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-to-announce-half-year-2022-financial-results-on-september-28-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20220922005704r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-to-announce-half-year-2022-financial-results-on-september-28-2022\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-to-announce-half-year-2022-financial-results-on-september-28-2022\/","name":"Nanobiotix to Announce Half Year 2022 Financial Results on September 28, 2022 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-to-announce-half-year-2022-financial-results-on-september-28-2022\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-to-announce-half-year-2022-financial-results-on-september-28-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20220922005704r1&sid=flmnd&distro=nx&lang=en","datePublished":"2022-09-22T20:18:48+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-to-announce-half-year-2022-financial-results-on-september-28-2022\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-to-announce-half-year-2022-financial-results-on-september-28-2022\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-to-announce-half-year-2022-financial-results-on-september-28-2022\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20220922005704r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20220922005704r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-to-announce-half-year-2022-financial-results-on-september-28-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Nanobiotix to Announce Half Year 2022 Financial Results on September 28, 2022"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/688249","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=688249"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/688249\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=688249"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=688249"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=688249"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}